The Autobio carbohydrate antigen 19-9 (CA19-9) chemiluminescence immunoassay (CLIA) kit is intended for the quantitative determination of CA19-9 concentration in human serum.
The CA19-9 is a carbohydrate antigen predominantly associated with gastrointestinal (GI) malignancies; pancreatic, colorectal, gastric and hepatic carcinomas. The main application of CA19-9 is in the management of diagnosed pancreatic and colorectal cancers. Immunochemically, CA 19-9 antigen is the sialated form of the blood group antigen Lewis. Clinical studies indicate that CA 19-9 assay levels have been found elevated in the serum with carcinomas of the exocrine pancreas, the colon and rectum, the stomach and lung cancer. It has been shown that a persistent elevation in CA19-9 assay value following treatment may be indicative of occult metastatic and/or residual disease. A persistently rising CA19-9 assay value may be associated with progressive malignant disease and poor therapeutic response. A declining CA19-9 assay value may be indicative of a favorable prognosis and a good response to treatment.
Increased serum CA19-9 assay values have also been observed in patients with nonmalignant conditions such as hepatitis, cirrhosis, pancreatitis, and other gastrointestinal disease. The CA 19-9 concentration should always be interpreted taking into consideration other clinical data and should not be used as a cancer screening test.
bio-equip.cn
About Group
Autobio is located at Zhengzhou, China and made up of Autobio Co., Ltd and Autobio Diagnostics Co., Ltd., which are all specialized in the field of providing solutions for clinical immunological diagnosis.
With GMP certified facilities and experienced staffs, we have developed high-quality in vitro diagnostic reagents with the competitive price.
In 2007 Autobio Labtec Instruments Co.Ltd. was founded, adding instrumentation to the product portfolio of the Autobio group. A close cooperation with an experienced R&D team in Europe and a highly qualified team in charge of production enables Autobio Labtec instruments to offer state of the art instrumentation to the domestic and international market.
Autobio Co. Ltd.
.. was established in 1998, as a company focusing on the sales and marketing of the range of diagnostic products developed and manufactured within Autobio group.
Autobio Diagnostics Co. Ltd.
... was established in 1999, and has become one of the largest and fastest growing clinical diagnostic companies in China. We are specialized in research & development, production and distribution of clinical diagnostic products which mainly focused on CLIA, ELISA, microbiology and Rapid Test Strips/devices.
中文
